England’s medical cannabis market has barely gotten off the ground since launching about 19 months ago, with a two-tier system in which few patients access products through legal channels while most resort to illicit suppliers.
Looking ahead, however, some industry insiders are hopeful that recently implemented import rules could boost the number of legal medical cannabis prescriptions from the currently low levels.
The number of “unlicensed” medical cannabis prescriptions issued in England continued to be negligible as of February 2020, Marijuana Business Daily has learned. Such products did not go through successful clinical trials to be granted a license to be marketed, but they can still be prescribed.
England’s National Health Service (NHS) has reimbursed patients on only a couple of dozen occasions for such products, also known as U-CBMPs, the National Health Service Business Services Authority told MJBizDaily in response to a Freedom of Information Act request.
Read full article here: https://mjbizdaily.com/little-growth-in-englands-medical-cannabis-market/